FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway

Published:2018-01 Issue:1 Volume:20 Page:44-56
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Tornin Juan,Hermida-Prado Francisco,Padda Ranjit Singh,Gonzalez M. Victoria,Alvarez-Fernandez Carlos,Rey Veronica,Martinez-Cruzado Lucia,Estupiñan Oscar,Menendez Sofia T.,Fernandez-Nevado Lucia,Astudillo Aurora,Rodrigo Juan P.,Lucien Fabrice,Kim Yohan,Leong Hon S.,Garcia-Pedrero Juana Maria,Rodriguez Rene

Funder

Agencia Estatal de Investigación

MINECO/Fondo Europeo de Desarrollo Regional

ISC III/FEDER

Plan de Ciencia Tecnología e Innovación del Principado de Asturias

Prostate Cancer Canada Rising Star Grant

Publisher

Elsevier BV

Subject

Cancer Research

Reference53 articles.

1. Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas;De Vita;Onco Targets Ther,2016

2. A mechanistic study on the metastasis inducing function of FUS-CHOP fusion protein in liposarcoma;Patil;Int J Cancer,2014

3. Trabectedin and campthotecin synergistically eliminate cancer stem cells in cell-of-origin sarcoma models;Martinez-Cruzado;Neoplasia,2017

4. The role of focal-adhesion kinase in cancer—a new therapeutic opportunity;McLean;Nat Rev Cancer,2005

5. Integrin-regulated FAK-Src signaling in normal and cancer cells;Mitra;Curr Opin Cell Biol,2006

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma;eBioMedicine;2024-04

2. Mesenchymal Stem Cells and Sarcoma;Comprehensive Hematology and Stem Cell Research;2024

3. A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma;2023-09-12

4. Cold plasma and inhibition of STAT3 selectively target tumorigenicity in osteosarcoma;Redox Biology;2023-06

5. Abrogation of stemness in osteosarcoma by the mithramycin analog EC-8042 is mediated by its ability to inhibit NOTCH-1 signaling;Biomedicine & Pharmacotherapy;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3